Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 53
Filter
1.
Eur J Orthop Surg Traumatol ; 27(4): 441-448, 2017 May.
Article in English | MEDLINE | ID: mdl-28424882

ABSTRACT

Achilles tendinopathy is a common overuse condition affecting the adult population. The incidence is on the rise because of greater participation of people in recreational or competitive sporting activities. There are several treatment options available both non-operative and operative. Ultrasound-guided dry needling and high-volume image-guided injection is relatively a new procedure. The aim of this study was to find out the effectiveness of dry needling and HVIGI in the management of mid-portion chronic Achilles tendinopathy by performing a literature review. Search strategy was devised to find the suitable articles for critical appraisal using the electronic databases. Four articles were selected for critical appraisal, and these papers showed good short- to long-term results of image-guided high-volume injection in the management of Achilles tendinopathy. We conclude that high-volume image-guided injection is effective in the management of Achilles tendinopathy. It provides good short- and medium-term relief of symptoms. It should be considered as one of the many options available for this condition.


Subject(s)
Achilles Tendon , Acupuncture Therapy/methods , Anesthetics, Local/administration & dosage , Cumulative Trauma Disorders/complications , Tendinopathy/therapy , Adult , Chronic Disease , Cumulative Trauma Disorders/physiopathology , Female , Follow-Up Studies , Humans , Injections, Intralesional , Male , Pain Measurement , Recovery of Function , Risk Assessment , Severity of Illness Index , Tendinopathy/diagnostic imaging , Tendinopathy/etiology , Treatment Outcome , Ultrasonography, Interventional/methods
2.
J Comp Neurol ; 521(13): 3042-56, 2013 Sep 01.
Article in English | MEDLINE | ID: mdl-23633129

ABSTRACT

Vesicular glutamate transporters (VGLUT1-3) carry glutamate into synaptic vesicles. VGLUT3 has been reported to be localized in nonglutamatergic neuronal populations in the brain. However, detailed subcellular localization of VGLUT3 has not been shown. In particular, the identity of synaptic vesicles expressing VGLUT3 remains to be revealed. Here we present novel electron microscopic postembedding immunogold data from mouse and rat brains showing that small, clear, and round synaptic vesicles in γ-aminobutyric acid (GABA)-ergic nerve terminals contain labeling for both VGLUT3 and the vesicular GABA transporter (VGAT). Immunoisolation of synaptic vesicles confirmed the immunogold data and showed vesicular colocalization of VGLUT3 and VGAT. Moreover, we show that gold particles signaling VGLUT3 are present in synaptic vesicles in acetylcholinergic nerve terminals in the striatum. Quantitative immunogold analyses reveal that the density of VGLUT3 gold particles is similar in GABAergic terminals in the hippocampus and the neocortex to that in cholinergic terminals in the striatum. In contrast to in the hippocampus and the neocortex, VGLUT3 was absent from VGAT-positive terminals in the striatum. The labeling pattern produced by the VGLUT3 antibodies was found to be specific; there was no labeling in VGLUT3 knockout tissue, and the observed labeling throughout the rat brain corresponds to the known light-microscopic distribution of VGLUT3. From the present results, we infer that glutamate is released with GABA from inhibitory terminals and acetylcholine from cholinergic terminals.


Subject(s)
Amino Acid Transport Systems, Acidic/metabolism , Brain/metabolism , Vesicular Inhibitory Amino Acid Transport Proteins/metabolism , Amino Acid Transport Systems, Acidic/deficiency , Amino Acid Transport Systems, Acidic/ultrastructure , Animals , Brain/cytology , Choline O-Acetyltransferase/metabolism , Gene Expression Regulation/genetics , Green Fluorescent Proteins/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Immunoelectron , Rats , Rats, Wistar , Synaptic Vesicles/metabolism , Synaptic Vesicles/ultrastructure , Vesicular Inhibitory Amino Acid Transport Proteins/ultrastructure
3.
Neuroradiol J ; 24(2): 242-8, 2011 May 15.
Article in English | MEDLINE | ID: mdl-24059614

ABSTRACT

Extrapontine myelinolysis (EPM) and cortical laminar necrosis (CLN) have rarely been reported in association with severe hypernatremia. We describe a patient with EPM associated with CLN following severe hypernatremia due to hypertonic peritoneal lavage after a ruptured hydatid cyst of the liver. Clinical and neuroimaging findings in acute stage and serial brain MRI at two and five month follow-up are discussed in detail.

4.
Neuroscience ; 164(3): 998-1008, 2009 Dec 15.
Article in English | MEDLINE | ID: mdl-19751803

ABSTRACT

Glutamine plays multiple roles in the CNS, including metabolic functions and production of the neurotransmitters glutamate and GABA. It has been proposed to be taken up into neurons via a variety of membrane transport systems, including system A, which is a sodium-dependent electrogenic amino acid transporter system. In this study, we investigate glutamine transport by application of amino acids to individual principal neurons of the medial nucleus of the trapezoid body (MNTB) in acutely isolated rat brain slices. A glutamine transport current was studied in patch-clamped neurons, which had the electrical and pharmacological properties of system A: it was sodium-dependent, had a non-reversing current-voltage relationship, was activated by proline, occluded by N-(methylamino)isobutyric acid (MeAIB), and was unaffected by 2-aminobicyclo-[2.2.1]-heptane-2-carboxylic acid (BCH). Additionally, we examined the expression of different system A transporter isoforms using immunocytochemical staining with antibodies raised against system A transporter 1 and 2 (SAT1 and SAT2). Our results indicate that both isoforms are expressed in MNTB principal neurons, and demonstrate that functional system A transporters are present in the plasma membrane of neurons. Since system A transport is highly regulated by a number of cellular signaling mechanisms and glutamine then goes on to activate other pathways, the study of these transporters in situ gives an indication of the mechanisms of neuronal glutamine supply as well as points of regulation of neurotransmitter production, cellular signaling and metabolism in the native neuronal environment.


Subject(s)
Amino Acid Transport System A/metabolism , Auditory Pathways/metabolism , Glutamine/metabolism , Neurons/metabolism , Rhombencephalon/metabolism , Animals , Auditory Pathways/cytology , Cell Membrane/metabolism , Cell Membrane/ultrastructure , Immunohistochemistry , Neurons/drug effects , Organ Culture Techniques , Patch-Clamp Techniques , Proline/metabolism , Proline/pharmacology , Protein Isoforms/metabolism , Rats , Rats, Wistar , Rhombencephalon/cytology , Signal Transduction/drug effects , Signal Transduction/physiology , Sodium Channel Blockers/pharmacology , beta-Alanine/analogs & derivatives , beta-Alanine/pharmacology
5.
Minerva Cardioangiol ; 57(3): 315-31, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19513012

ABSTRACT

The utilization of stress echocardiography has undergone considerable expansion and evolution over the past three decades. Although stress echocardiography was first conceived as a noninvasive diagnostic tool for determining the presence or absence of coronary artery disease (CAD), its prognostic value is now well established. Thus, identification of patients at risk for future cardiac events has become a primary objective in the noninvasive evaluation of patients with chest pain syndromes and among patients with known CAD. In particular, the ability of stress echocardiography to identify patients at low (<1%), intermediate (1-5%) or high (>5%) risk for future cardiac events is essential to patient management decisions. Moreover, previous studies have conclusively demonstrated the incremental prognostic value of stress echocardiography over clinical and treadmill exercise data, in predicting future cardiac events. This review addresses the current role and summarizes current literature with respect to the use of stress echocardiography in determining patient risk for cardiac events and the cost-effective integration of such information into patient management decisions.


Subject(s)
Chest Pain/diagnostic imaging , Chest Pain/economics , Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/economics , Echocardiography, Stress/economics , Chest Pain/diagnosis , Coronary Artery Disease/diagnosis , Cost-Benefit Analysis , Humans , New York City , Outcome Assessment, Health Care , Predictive Value of Tests , Prognosis , Risk Assessment , Risk Factors , Severity of Illness Index
6.
Biochem Biophys Res Commun ; 381(3): 378-82, 2009 Apr 10.
Article in English | MEDLINE | ID: mdl-19233140

ABSTRACT

Insulin and glucagon secretion from the islets of Langerhans is highly regulated. Although an increased plasma glucose level is the major stimulus for insulin exocytosis, roles for glutamine and glutamate have been suggested. Interestingly, the islet cells display elements associated with synaptic transmission. In the central nervous system (CNS), glutamine transport by SN1 and SAT2 sustain the generation of neurotransmitter glutamate. We hypothesized that the same transporters are essential for glutamine transport into the islet cells and for subsequent formation of glutamate acting as an intracellular signaling molecule. We demonstrate that islet cells express several transporters which can mediate glutamine transport. In particular, we show pronounced expression of SN1 and SAT2 in B-cells and A-cells, respectively. The cell-specific expression of these transporters together with their functional characteristics suggest an important role for glutamine in the regulation of insulin secretion.


Subject(s)
Acetyltransferases/biosynthesis , Amino Acid Transport Systems, Neutral/biosynthesis , Glucagon-Secreting Cells/metabolism , Glutamine/metabolism , Insulin-Secreting Cells/metabolism , Insulin/metabolism , Acetyltransferases/genetics , Amino Acid Transport Systems, Neutral/genetics , Animals , Biological Transport , Insulin Secretion , Mice , Rats , Rats, Wistar
7.
J Pak Med Assoc ; 53(3): 125-9, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12779031

ABSTRACT

OBJECTIVE: To determine the seasonal variation of the commonly isolated bacterial pathogens in stool samples. MATERIAL AND METHODS: A retrospective descriptive study was undertaken of all the stool samples submitted from within Karachi to the Aga Khan University Hospital Laboratory over a period of five years (January 1997- December 2001) in order to determine the commonly isolated bacterial pathogens and to predict their seasonal variation. RESULTS: A total of 16379 stool samples were included in this review. Bacterial isolates were found in 6670 stool samples (culture detection rate=40.7%). The mean age at the time of culture of each sub-group was < or = 1 year group (6.58 +/- 3.1 months), 1-5 years (2.13 +/- 0.94 years), 5-14 years (8.3 +/- 2.6 yrs) and adults (43.2 +/- 18.5 years). Male: Female ratio was 1.2:1. Vibrio cholera 01 Ogawa (32.8%), Campylobacter jejuni (17.3%), Enteropathogenic Escherichia coli (9.9%), Salmonella paratyphi b (6.6%) and Shigella flexneri (6.2%) were the most common organisms isolated. These organisms show a distinct seasonal variation with summer predilection. CONCLUSION: In contrast to the previous studies from South Asia, which have identified E. coil, followed by Vibrio cholerae as the most common enteric isolates, we found Vibrio cholera 01 Ogawa followed by Campylobacter jejuni as the most common enteric pathogens isolated in an urban setting. It is important to consider seasonal variation when empirically treating diarrheal diseases in our region.


Subject(s)
Bacteria/isolation & purification , Feces/microbiology , Seasons , Adolescent , Adult , Child , Child, Preschool , Diarrhea/microbiology , Female , Gastroenteritis/microbiology , Humans , Infant , Male , Pakistan , Retrospective Studies
8.
Echocardiography ; 18(7): 553-7, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11737963

ABSTRACT

UNLABELLED: Human studies have suggested that Doppler transesophageal echocardiography (TEE) can determine normal physiologic coronary blood flow (CBF) and alterations in CBF due to proximal flow-limiting stenoses. However, assessment of CBF by Doppler TEE has not been validated. To determine if true estimation of CBF could be obtained with Doppler TEE, seven mongrel dogs (weight range 28 kg-36 kg) were evaluated. Simultaneous CBF determinations by Doppler TEE and epicardial electromagnetic flow (EMF) and/or epicardial Doppler flow (EDF) probes were compared. Measurements were obtained at baseline and following varying degrees of proximal coronary occlusion, which produced reactive hyperemia. RESULTS: Consistent Doppler flow waveforms were obtainable by Doppler TEE in 34 different measurements during perturbations: Mean for TEE Flow (ml/min) = 85, EMF or EDF Flow (ml/min) = 53; Standard Deviation for TEE Flow (ml/min) = 45, EMF or EDF Flow (ml/min) = 38; Minimum for TEE Flow (ml/min) = 42, EMF or EDF Flow (ml/min) = 11; and Maximum for TEE Flow (ml/min) = 174, EMF or EDF Flow (ml/min) = 130. TEE Flow (ml/min) = 1.1 EMF/EDF flow + 26.3. There was a general trend towards overestimation of CBF by Doppler TEE. This study demonstrates that Doppler TEE is a promising method for obtaining measurements of CBF over the physiologic range.


Subject(s)
Coronary Circulation/physiology , Coronary Vessels/diagnostic imaging , Echocardiography, Transesophageal/methods , Animals , Blood Flow Velocity , Confidence Intervals , Dogs , Linear Models , Models, Animal , Probability , Reference Values , Sensitivity and Specificity , Ultrasonography, Doppler/methods
9.
EMBO J ; 20(24): 7041-51, 2001 Dec 17.
Article in English | MEDLINE | ID: mdl-11742981

ABSTRACT

The system N transporter SN1 has been proposed to mediate the efflux of glutamine from cells required to sustain the urea cycle and the glutamine-glutamate cycle that regenerates glutamate and gamma-aminobutyric acid (GABA) for synaptic release. We now show that SN1 also mediates an ionic conductance activated by glutamine, and this conductance is selective for H(+). Although SN1 couples amino acid uptake to H(+) exchange, the glutamine-gated H(+) conductance is not stoichiometrically coupled to transport. Protons thus permeate SN1 both coupled to and uncoupled from amino acid flux, providing novel mechanisms to regulate the transfer of glutamine between cells.


Subject(s)
Amino Acid Transport Systems/metabolism , Animals , Astrocytes/metabolism , Glutamic Acid/metabolism , Glutamine/metabolism , Ion Channel Gating , Protons , Xenopus , gamma-Aminobutyric Acid/metabolism
10.
Prog Cardiovasc Dis ; 43(4): 351-61, 2001.
Article in English | MEDLINE | ID: mdl-11235849

ABSTRACT

Left ventricular function is one of the most important determinates of long-term prognosis in patients with coronary artery disease. In recent years, it has become apparent that left ventricular dysfunction in patients with coronary artery disease is not always an irreversible process stemming from myocardial necrosis and fibrosis. Myocardial tissue can undergo both a state of potential reversible dysfunction because of prolonged sustained ischemia (hibernating myocardium) or episodes of acute ischemia (stunned myocardium). Revascularization of this tissue may improve regional and global left ventricular function and therefore prognosis. Numerous studies have now firmly established dobutamine echocardiography as a safe, reliable, and accurate imaging modality in the assessment of reversible left ventricular dysfunction. Furthermore, dobutamine echocardiography has been shown to have good sensitivity, specificity, and, more importantly, positive predictive accuracy in identifying both acute and chronic reversible left ventricular dysfunction for risk satisfaction and prognosis.


Subject(s)
Myocardial Stunning/diagnostic imaging , Ventricular Dysfunction, Left/diagnostic imaging , Cardiotonic Agents , Dipyridamole , Dobutamine , Echocardiography/methods , Exercise Test , Humans , Nitroglycerin , Prognosis , Risk Assessment , Vasodilator Agents , Ventricular Dysfunction, Left/physiopathology
11.
J Am Coll Cardiol ; 36(6): 1913-9, 2000 Nov 15.
Article in English | MEDLINE | ID: mdl-11092664

ABSTRACT

OBJECTIVES: We evaluated a novel protocol of dual-isotope, gated single-photon emission computed tomographic (SPECT) imaging combined with low and high dose dobutamine as a single test for the characterization of various types of altered myocardial dysfunction. BACKGROUND: Myocardial perfusion tomography and echocardiography have been used separately for the assessment of myocardial viability. However, it is possible to assess perfusion, function and contractile reserve using gated SPECT imaging. METHODS: We studied 54 patients with ischemic cardiomyopathy using rest and 4 h redistribution thallium-201 imaging and dobutamine technetium-99m sestamibi SPECT imaging. The sestamibi images were acquired 1 h after infusion of the maximal tolerated dose of dobutamine and again during infusion of dobutamine at a low dose to estimate contractile reserve. Myocardial segments were defined as hibernating, stunned, remodeled or scarred. RESULTS: Severe regional dysfunction was present in 584 (54%) of 1,080 segments. Based on the combination of function and perfusion characteristics in these 584 segments, 24% (n = 140) were labeled as hibernating; 23% (n = 136) as stunned; 30% (n = 177) as remodeled; and 22% (n = 131) as scarred. Contractile reserve, represented by improvement in wall motion/thickening by low dose dobutamine, was observed in 83% of stunned, 59% of hibernating, 35% of remodeled and 13% of scarred myocardial segments (p<0.05). CONCLUSIONS: It is possible with this new imaging technique to characterize dysfunctional myocardium as stunned, hibernating, remodeled and nonviable. These subtypes often coexist in the same patient.


Subject(s)
Myocardial Ischemia/diagnostic imaging , Tomography, Emission-Computed, Single-Photon/methods , Aged , Cardiotonic Agents/administration & dosage , Dobutamine/administration & dosage , Feasibility Studies , Female , Humans , Male , Middle Aged , Myocardial Stunning/diagnostic imaging
12.
Echocardiography ; 17(1): 61-7, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10978962

ABSTRACT

The extent and degree of myocardial viability is an important parameter in the risk stratification of patients with significant left ventricular dysfunction due to coronary artery disease (CAD). Although several imaging modalities can identify viable myocardium, dobutamine stress echocardiography has gained considerable importance as an accurate, safe, and reliable method. In patients with significant left ventricular dysfunction secondary to CAD, identifying the presence and extent of contractile reserve and, therefore, viable myocardium, during low dose dobutamine infusion can predict recovery of left ventricular function postrevascularization, survival, and future cardiac events.


Subject(s)
Echocardiography/methods , Myocardial Contraction/physiology , Myocardial Ischemia/diagnostic imaging , Cardiotonic Agents/administration & dosage , Dobutamine/administration & dosage , Exercise Test , Humans , Infusions, Intravenous , Myocardial Ischemia/complications , Myocardial Ischemia/physiopathology , Prognosis , Reproducibility of Results , Ventricular Dysfunction, Left/diagnostic imaging , Ventricular Dysfunction, Left/etiology , Ventricular Dysfunction, Left/physiopathology
13.
Echocardiography ; 17(3): 241-53, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10978988

ABSTRACT

The diagnostic accuracy of dobutamine stress echocardiography is limited in patients with poor transthoracic acoustic windows. Transesophageal echocardiography (TEE) overcomes these limitations and thus may increase the clinical usefulness of dobutamine stress echocardiography. The present study was designed to compare the diagnostic accuracies of transesophageal and transthoracic dobutamine stress echocardiography for the identification of coronary artery disease (CAD) in a cohort of patients with a higher incidence of poor acoustic windows. Forty-two male patients (mean age, 66 +/- 9 years) underwent dobutamine stress echocardiography with simultaneous transesophageal and transthoracic imaging. Coronary arteriography was performed in 28 patients (67%). Transesophageal imaging adequately visualized 99.6% of left ventricular segments compared with 76.2% visualized by transthoracic imaging (P < 0.0001). There was substantial agreement between the two techniques for segmental wall motion analysis at baseline (kappa 0.76; 95% CI, 0.70-0.82); however, at peak dobutamine dose, agreement was significantly reduced (kappa 0.62; 95% CI, 0.55-0.69). The sensitivity (88% vs 75%), specificity (100% vs 75%), and positive predictive value (100% vs 80%) for the identification of CAD were all superior for transesophageal imaging. Transesophageal imaging correctly identified 11 of the 12 patients (92%) with multivessel disease compared with 5 patients (42%) identified by transthoracic imaging (P < 0.03). There were no major complications. Transesophageal dobutamine stress echocardiography is a safe, feasible, and accurate technique for the identification and risk stratification of patients with CAD. Transesophageal imaging appears to be superior to transthoracic imaging for identifying both the presence and extent of CAD, specifically in patients with poor acoustic windows.


Subject(s)
Dobutamine , Echocardiography, Transesophageal , Echocardiography , Myocardial Ischemia/diagnostic imaging , Sympathomimetics , Aged , Coronary Angiography , Coronary Disease/diagnostic imaging , Humans , Male , Predictive Value of Tests , Risk Assessment , Sensitivity and Specificity
14.
15.
Echocardiography ; 17(5): 495-506, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10979026

ABSTRACT

The extent and degree of myocardial viability are important parameters in the risk stratification of patients with significant left ventricular dysfunction secondary to coronary artery disease. Although several imaging modalities can identify viable myocardium, dobutamine stress echocardiography has gained considerable importance as an accurate, safe, and reliable method. In patients with significant left ventricular dysfunction secondary to coronary artery disease, identification of the presence and extent of contractile reserve and, therefore, viable myocardium during low-dose dobutamine infusion can predict the recovery of left ventricular function after revascularization, survival rate, and future cardiac events.


Subject(s)
Echocardiography , Ventricular Dysfunction, Left/diagnostic imaging , Contrast Media , Dipyridamole , Dobutamine , Humans , Nitroglycerin , Prognosis
16.
Echocardiography ; 17(5): 507-12, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10979027

ABSTRACT

Exercise and pharmacological stress echocardiography are well-accepted techniques of evaluating coronary artery disease in adults. In children, however, experience with stress echocardiography is limited and continues to evolve. The objective of this focused review was to describe the experience with exercise and dobutamine stress echocardiography in the pediatric population, with an emphasis on technique, current indications, and future directions. Experience is reported in children with prior Kawasaki disease or heart transplant recipients, as well as patients with congenital coronary abnormalities. In addition, stress echocardiography has been used in patients who have undergone coronary artery bypass graft surgery to evaluate short- and long-term graft patterning. Stress echocardiography appears to be a feasible, safe, and useful modality for the noninvasive assessment of flow-limiting stenosis in the pediatric population and can be used serially in the routine follow-up and risk stratification in children at risk for coronary events.


Subject(s)
Dobutamine , Echocardiography , Exercise Test , Child , Coronary Vessel Anomalies/diagnostic imaging , Heart Defects, Congenital/diagnostic imaging , Heart Transplantation , Humans , Mucocutaneous Lymph Node Syndrome/diagnostic imaging
17.
Echocardiography ; 17(6 Pt 1): 547-54, 2000 Aug.
Article in English | MEDLINE | ID: mdl-11000589

ABSTRACT

The objective of this article was to determine whether the presence of left ventricular apical thrombus is a marker of nonviable myocardium. Reduced coronary blood flow secondary to atherosclerosis may result in chronic reversible left ventricular wall-motion abnormalities. Severe regional abnormalities also predispose to formation of left ventricular thrombus. The relationship between left ventricular apical thrombus and myocardial viability has not been previously described. Eighty patients with coronary artery disease and chronic left ventricular dysfunction were studied by dobutamine stress echocardiography. Left ventricular apical thrombus was identified using echocardiographic criteria. Wall-motion analysis was performed using a standard 16-segment model and ejection fraction was calculated. As a result, 48 patients (60%) had definite or highly suspicious findings for left ventricular thrombus (group 1), and 32 patients (40%) had no thrombus (group 2). Group 1 had significantly higher composite (54.0 +/- 5.8 vs 43.3 +/- 6.4) and apical (6.0 +/- 2.7 vs 12.4 +/- 3.4) wall-motion scores compared to those in group 2 (P = 0.01). Thirty-two patients (67%) in group 1 demonstrated no contractile reserve in the apical segments, consistent with lack of viability, versus eight patients (25%) in group 2 (P = 0.0003). The number of viable apical segments per patient was significantly less in group 1 (0.7 +/- 1.2) versus group 2 (1.8 +/- 1.3) (P = 0.01). Left ventricular apical thrombus is more likely to be present when there is absence of myocardial viability in the corresponding segments.


Subject(s)
Echocardiography , Heart Diseases/diagnostic imaging , Thrombosis/diagnostic imaging , Ventricular Dysfunction, Left/diagnostic imaging , Adult , Aged , Aged, 80 and over , Chi-Square Distribution , Coronary Disease/complications , Dobutamine , Exercise Test , Female , Heart Diseases/etiology , Heart Ventricles/diagnostic imaging , Humans , Male , Middle Aged , Myocardial Contraction , Probability , Risk Assessment , Stroke Volume , Thrombosis/etiology , Ventricular Dysfunction, Left/etiology
18.
Proc Natl Acad Sci U S A ; 97(14): 7715-20, 2000 Jul 05.
Article in English | MEDLINE | ID: mdl-10859363

ABSTRACT

Classical amino acid transport System A accounts for most of the Na(+)-dependent neutral amino acid uptake by mammalian cells. System A has also provided a paradigm for short- and long-term regulation by physiological stimuli. We now report the isolation of a cDNA encoding System A that shows close similarity to the recently identified System N transporter (SN1). The System A transporter (SA1) and SN1 share many functional characteristics, including a marked sensitivity to low pH, but, unlike SN1, SA1 does not mediate proton exchange. Transport mediated by SA1 is also electrogenic. Amino acid transport Systems A and N thus appear closely related in function as well as structure, but exhibit important differences in ionic coupling.


Subject(s)
Amino Acid Transport Systems, Neutral , Amino Acids/metabolism , Carrier Proteins/metabolism , Membrane Transport Proteins , Amino Acid Sequence , Amino Acid Transport Systems , Animals , Biological Transport , Carrier Proteins/chemistry , Electrophysiology , Gene Library , Humans , In Situ Hybridization , Membrane Potentials , Models, Molecular , Molecular Sequence Data , Protons , Rats , Recombinant Proteins/metabolism , Sequence Analysis, DNA , Sodium/metabolism , Tissue Distribution , beta-Alanine/analogs & derivatives , beta-Alanine/metabolism
19.
J Neurosci ; 20(10): 3537-43, 2000 May 15.
Article in English | MEDLINE | ID: mdl-10804194

ABSTRACT

Protein phosphatase inhibitor-1 (I-1) has been proposed as a regulatory element in the signal transduction cascade that couples postsynaptic calcium influx to long-term changes in synaptic strength. We have evaluated this model using mice lacking I-1. Recordings made in slices prepared from mutant animals and also in anesthetized mutant animals indicated that long-term potentiation (LTP) is deficient at perforant path-dentate granule cell synapses. In vitro, this deficit was restricted to synapses of the lateral perforant path. LTP at Schaffer collateral-CA1 pyramidal cell synapses remained normal. Thus, protein phosphatase-1-mediated regulation of NMDA receptor-dependent synaptic plasticity involves heterogeneous molecular mechanisms, in both different dendritic subregions and different neuronal subtypes. Examination of the performance of I-1 mutants in spatial learning tests indicated that intact LTP at lateral perforant path-granule cell synapses is either redundant or is not involved in this form of learning.


Subject(s)
Carrier Proteins , Intracellular Signaling Peptides and Proteins , Long-Term Potentiation/genetics , Neuronal Plasticity/genetics , Phosphoprotein Phosphatases/metabolism , RNA-Binding Proteins/genetics , Animals , Dentate Gyrus/cytology , Dentate Gyrus/physiology , Excitatory Postsynaptic Potentials/physiology , Female , Gene Expression/physiology , Male , Maze Learning/physiology , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Perforant Pathway/cytology , Phosphoproteins/metabolism , Protein Phosphatase 1 , Pyramidal Cells/chemistry , Pyramidal Cells/enzymology , RNA-Binding Proteins/analysis , RNA-Binding Proteins/metabolism , Space Perception/physiology , Synapses/chemistry , Synapses/enzymology , Water
20.
Arch Virol ; 145(1): 73-84, 2000.
Article in English | MEDLINE | ID: mdl-10664407

ABSTRACT

Viral hepatitis is a common infection in the developing countries. Aside from Hepatitis A-E viruses, a novel hepatitis virus termed GBV-C, or HGV, was recently described. We have studied the prevalence of this virus among Saudi Arabian healthy blood donors (n = 200) and patients with cryptogenic (non-A-E) hepatitis (n=71). After serum extraction and RNA reverse transcription, amplification was carried out by the polymerase chain reaction (PCR), using primers for the 5' noncoding region (NCR), NS5A region and NS3 helicase region. Among the patients with cryptogenic hepatitis, PCR-positivity was 18/71 (25.4%) for the 5' NCR, 14/71 (19.7%) for the NS5A region, and 15/71 (21.1%) for the NS3 helicase region. Among the healthy blood donors, PCR-positivity was 4/200 (2%) for the 5' NCR, 0/200 (0%) for the NS5A region, and 1/200 (0.5%) for the NS3 helicase region. Since the 5' NCR is considered the most conserved segment of the virus genome, it is not unusual to find higher positivity rate when that region is used for amplification. It is noted that the positivity rate is not far different among the three amplified regions, indicating that the heterogeneity of GBV-C/HGV is not as extensive as in hepatitis C virus. Phylogenetic analysis of 5'NCR DNA sequences showed that all isolates in this study belong to genotype 2. We conclude that the prevalence of GBV-C/HGV is similar to what is reported worldwide among the general Saudi population but relatively higher among Saudi patients with cryptogenic hepatitis.


Subject(s)
Blood Donors , Flaviviridae/genetics , Hepatitis, Viral, Human/epidemiology , Hepatitis, Viral, Human/virology , 5' Untranslated Regions/genetics , Amino Acid Sequence , Base Sequence , Cloning, Molecular , DNA Primers , DNA Probes , Flaviviridae/chemistry , Flaviviridae/classification , Humans , Molecular Sequence Data , Prevalence , RNA Helicases/chemistry , RNA Helicases/genetics , RNA, Viral/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction , Saudi Arabia/epidemiology , Sequence Analysis, DNA , Serine Endopeptidases , Viral Nonstructural Proteins/chemistry , Viral Nonstructural Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL